Arudein

Arudein may be available in the countries listed below.

Ingredient matches for Arudein

Piroxicam

Piroxicam is reported as an ingredient of Arudein in the following countries:

• Japan

International Drug Name Search

Frenasma

Frenasma may be available in the countries listed below.

Ingredient matches for Frenasma

Ketotifen

Ketotifen is reported as an ingredient of Frenasma in the following countries:

• Romania

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Frenasma in the following countries:

• Greece

International Drug Name Search

Alkala

Alkala may be available in the countries listed below.

Ingredient matches for Alkala

Sodium Bicarbonate

Sodium Bicarbonate is reported as an ingredient of Alkala in the following countries:

• Germany

International Drug Name Search

Propiomazine

In the US, Propiomazine is a member of the drug class miscellaneous anxiolytics, sedatives and hypnotics.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05CM06

CAS registry number (Chemical Abstracts Service)

0000362-29-8

Chemical Formula

C20-H24-N2-O-S

Molecular Weight

340

Therapeutic Categories

Antiemetic

Hypnotic and sedative agent

Antihistaminic agent

Chemical Name

1-Propanone, 1-[10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl]-

Foreign Names

• Propiomazinum (Latin)
• Propiomazin (German)
• Propiomazine (French)
• Propiomazina (Spanish)

Generic Names

• Propiomazine (OS: BAN, USAN, DCF)
• CB 1678 (IS)
• Wy 1359 (IS)

Brand Name

• Propavan
  Sanofi-Aventis, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Totamol

Totamol may be available in the countries listed below.

Ingredient matches for Totamol

Atenolol

Atenolol is reported as an ingredient of Totamol in the following countries:

• Malta


• Oman

International Drug Name Search

Donacom

Donacom may be available in the countries listed below.

Ingredient matches for Donacom

Glucosamine

Glucosamine is reported as an ingredient of Donacom in the following countries:

• Belgium

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Donacom in the following countries:

• Norway

Glucosamine sulfate sodium chloride (a derivative of Glucosamine) is reported as an ingredient of Donacom in the following countries:

• Sweden

International Drug Name Search

Dallergy Sustained-Release and Long-Acting Tablets

Pronunciation: KLOR-fen-IR-a-meen/FEN-il-EF-rin/METH-skoe-POL-a-meen
Generic Name: Chlorpheniramine/Phenylephrine/Methscopolamine
Brand Name: Examples include Aerohist Plus and Dallergy

Dallergy Sustained-Release and Long-Acting Tablets are used for:

Relieving congestion, sneezing, runny nose, and itchy, watery eyes due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.

Dallergy Sustained-Release and Long-Acting Tablets are an antihistamine, decongestant, and anticholinergic combination. It works by blocking histamine, a substance in the body that causes sneezing, runny nose, and watery eyes. It also relieves nasal congestion by shrinking the nasal mucous membranes, which promotes nasal drainage, and dries the chest by decreasing lung secretions.

Do NOT use Dallergy Sustained-Release and Long-Acting Tablets if:

• you are allergic to any ingredient in Dallergy Sustained-Release and Long-Acting Tablets


• you are pregnant or breast-feeding


• you take sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days


• you have a history of narrow-angle glaucoma, blockage in the stomach or intestines, peptic ulcer disease, intestinal or bowel problems, difficulty urinating, inflammation of the esophagus from reflux disease, difficulty swallowing, or uncontrolled bleeding


• you have severe heart disease or severe high blood pressure

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dallergy Sustained-Release and Long-Acting Tablets:

Some medical conditions may interact with Dallergy Sustained-Release and Long-Acting Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you are taking or have taken medicine for high blood pressure or depression in the last 14 days


• if you have diabetes, an enlarged prostate, a history of bladder or kidney problems, high blood pressure, diarrhea, asthma, nerve problems, heart problems, blood clots, a hiatal hernia, an adrenal gland tumor, glaucoma or increased pressure in the eye, breathing problems during sleep, myasthenia gravis (muscle weakness), lung problems, liver problems, Down syndrome, blood vessel problems, or an overactive thyroid

Some MEDICINES MAY INTERACT with Dallergy Sustained-Release and Long-Acting Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Alpha-blockers (eg, guanethidine, methyldopa, prazosin), beta-blockers (eg, atenolol), diuretics (eg, furosemide, hydrochlorothiazide), furazolidone, or MAOIs (eg, phenelzine) because the risk of high or low blood pressure may be increased


• Alkalizers (eg, calcium or magnesium antacids), anticholinergics (eg, atropine, benztropine, dicyclomine), carbonic anhydrase inhibitors (eg, acetazolamide), ergotamine, sodium bicarbonate, or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Dallergy Sustained-Release and Long-Acting Tablets's side effects


• Bromocriptine, catechol-O-methyltransferase (COMT) inhibitors (eg, entacapone), certain stimulants (eg, doxapram, pseudoephedrine), cocaine, digoxin, droxidopa, potassium chloride, or sodium oxybate ( GHB) because the risk of their side effects may be increased by Dallergy Sustained-Release and Long-Acting Tablets


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Dallergy Sustained-Release and Long-Acting Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dallergy Sustained-Release and Long-Acting Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dallergy Sustained-Release and Long-Acting Tablets:

Use Dallergy Sustained-Release and Long-Acting Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Dallergy Sustained-Release and Long-Acting Tablets by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Swallow Dallergy Sustained-Release and Long-Acting Tablets whole. Do not break, crush, or chew before swallowing. Some brands of Dallergy Sustained-Release and Long-Acting Tablets may be broken in half before taking. If you have difficulty swallowing the whole tablet, ask your pharmacist if your brand of medicine may be broken in half.


• Do not take Dallergy Sustained-Release and Long-Acting Tablets at the same time as antacids, certain medicines for diarrhea (eg, attapulgite, bismuth, kaolin, pectin), or ketoconazole. Take these medicines 2 or 3 hours before or after you take Dallergy Sustained-Release and Long-Acting Tablets.


• If you miss a dose of Dallergy Sustained-Release and Long-Acting Tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dallergy Sustained-Release and Long-Acting Tablets.

Important safety information:

• Dallergy Sustained-Release and Long-Acting Tablets may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Dallergy Sustained-Release and Long-Acting Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Dallergy Sustained-Release and Long-Acting Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• If your symptoms do not get better within 7 days or if you develop a high fever or persistent headache, check with your doctor.


• Dallergy Sustained-Release and Long-Acting Tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Dallergy Sustained-Release and Long-Acting Tablets.


• Dallergy Sustained-Release and Long-Acting Tablets may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Dallergy Sustained-Release and Long-Acting Tablets for a few days before the tests.


• Dallergy Sustained-Release and Long-Acting Tablets may cause dry mouth. To relieve dry mouth, suck on sugarless hard candy or ice chips, chew sugarless gum, drink water, or use a saliva substitute.


• Dallergy Sustained-Release and Long-Acting Tablets may make your eyes more sensitive to sunlight. It may help to wear sunglasses.


• Dallergy Sustained-Release and Long-Acting Tablets may reduce sweating. Do not become overheated in hot weather or while you are being active; heatstroke may occur.


• Do not take diet or appetite control medicines while you are taking Dallergy Sustained-Release and Long-Acting Tablets without checking with your doctor.


• If you have trouble sleeping, ask your doctor or pharmacist about the best time of the day to take Dallergy Sustained-Release and Long-Acting Tablets.


• Diabetes patients - Dallergy Sustained-Release and Long-Acting Tablets may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Use Dallergy Sustained-Release and Long-Acting Tablets with caution in the ELDERLY; they may be more sensitive to its effects.


• Dallergy Sustained-Release and Long-Acting Tablets should not be used in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dallergy Sustained-Release and Long-Acting Tablets while you are pregnant. Do not use Dallergy Sustained-Release and Long-Acting Tablets during labor or delivery because it may cause harm to the fetus. Dallergy Sustained-Release and Long-Acting Tablets are found in breast milk. Do not breast-feed while taking Dallergy Sustained-Release and Long-Acting Tablets.

Possible side effects of Dallergy Sustained-Release and Long-Acting Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Blurred vision; clumsiness; constipation; dizziness; drowsiness; dry mouth, nose, or throat; excitability or irritability (especially in children); flushing; giddiness; headache; lack of energy; nausea; nervousness; tearing; trouble sleeping; unusual tiredness or weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; difficulty swallowing; fast or irregular heartbeat; hallucinations; mental or mood changes; pounding in the chest; sore throat with fever; trouble urinating; unusual bleeding or bruising; vomiting.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dallergy side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include deep sleep or loss of consciousness; hot or cool skin; irregular heartbeat; irritability, anxiety, or panic; large pupils; numbness or tingling in the arms or legs; seizures; slowed or shallow breathing; vomiting.

Proper storage of Dallergy Sustained-Release and Long-Acting Tablets:

Store Dallergy Sustained-Release and Long-Acting Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C) in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dallergy Sustained-Release and Long-Acting Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Dallergy Sustained-Release and Long-Acting Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Dallergy Sustained-Release and Long-Acting Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dallergy Sustained-Release and Long-Acting Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dallergy resources

• Dallergy Side Effects (in more detail)
• Dallergy Use in Pregnancy & Breastfeeding
• Dallergy Drug Interactions
• Dallergy Support Group
• 4 Reviews for Dallergy - Add your own review/rating

Compare Dallergy with other medications

• Nasal Congestion
• Rhinitis

DesOwen 2 oz

Generic Name: desonide topical (DES oh nide)

Brand Names: Delonide, Desonate, DesOwen, DesOwen 2 oz, DesOwen Lotion 4 oz Kit, LoKara, Tridesilon, Verdeso

What is DesOwen 2 oz (desonide topical)?

Desonide is a topical (for the skin) steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.

Desonide topical is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.

Desonide topical may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about DesOwen 2 oz (desonide topical)?

Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.

Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with desonide topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period. Contact your doctor if your condition does not improve after 2 weeks of using this medicine, or if you develop signs of a bacterial, fungal, or viral skin infection.

What should I discuss with my healthcare provider before using DesOwen 2 oz (desonide topical)?

Do not use this medication if you are allergic to desonide.

Before using desonide topical, tell your doctor if you are allergic to any drugs, or if you have any type of skin infection.

Also tell your doctor if you have diabetes. Topical steroid medicines absorbed through the skin may increase the glucose (sugar) levels in your blood or urine.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether desonide topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period.

How should I use DesOwen 2 oz (desonide topical)?

Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.

Wash your hands before and after using desonide topical, unless you are using the medication to treat the skin on your hands.

Apply a small amount to the affected area and rub it gently into the skin. Do not use this medication over a large area of skin.

Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with desonide topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Contact your doctor if your condition does not improve after 2 weeks of using this medicine, or if you develop signs of a bacterial, fungal, or viral skin infection. It is important to use desonide topical regularly to get the most benefit.

To be sure this medication is not causing harmful effects with long-term use, you may need blood tests. Do not miss any scheduled appointments.

Store desonide topical at room temperature away from moisture and heat. Keep from freezing.

What happens if I miss a dose?

Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of desonide is not expected to produce life-threatening symptoms. However, long-term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.

What should I avoid while using DesOwen 2 oz (desonide topical)?

Desonide topical should not be used to treat any skin condition your doctor has not prescribed it for.

Avoid getting this medication in your eyes. If contact does occur, rinse with water. Do not use desonide topical on broken or infected skin. Also avoid using this medication in open wounds.

DesOwen 2 oz (desonide topical) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing desonide topical through your skin, such as:

• 
  

  blurred vision, or seeing halos around lights;

  
  


• 
  

  mood changes;

  
  


• 
  

  sleep problems (insomnia);

  
  


• 
  

  weight gain, puffiness in your face; or

  
  


• 
  

  muscle weakness, feeling tired.

  
  

Less serious side effects may include:

• 
  

  mild skin itching, redness, burning, or peeling;

  
  


• 
  

  dryness or scaly skin;

  
  


• 
  

  thinning or softening of your skin;

  
  


• 
  

  skin rash or irritation around your mouth;

  
  


• 
  

  swollen hair follicles;

  
  


• 
  

  changes in color of treated skin;

  
  


• 
  

  blisters, pimples, or crusting of treated skin; or

  
  


• 
  

  stretch marks.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect DesOwen 2 oz (desonide topical)?

It is not likely that other drugs you take orally or inject will have an effect on topically applied desonide topical. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More DesOwen 2 oz resources

• DesOwen 2 oz Side Effects (in more detail)
• DesOwen 2 oz Use in Pregnancy & Breastfeeding
• DesOwen 2 oz Drug Interactions
• DesOwen 2 oz Support Group
• 5 Reviews for DesOwen 2 oz - Add your own review/rating

• DesOwen Cream MedFacts Consumer Leaflet (Wolters Kluwer)


• DesOwen Cream Kit Cream MedFacts Consumer Leaflet (Wolters Kluwer)


• Desonate Consumer Overview


• Desonate Advanced Consumer (Micromedex) - Includes Dosage Information


• Desonate Gel MedFacts Consumer Leaflet (Wolters Kluwer)


• Desonate Prescribing Information (FDA)


• Desowen Prescribing Information (FDA)


• LoKara Prescribing Information (FDA)


• LoKara Lotion MedFacts Consumer Leaflet (Wolters Kluwer)


• Verdeso Prescribing Information (FDA)


• Verdeso Consumer Overview


• Verdeso Foam MedFacts Consumer Leaflet (Wolters Kluwer)

Compare DesOwen 2 oz with other medications

• Atopic Dermatitis
• Dermatitis
• Eczema
• Psoriasis

Where can I get more information?

• Your pharmacist can provide more information about desonide topical.

See also: DesOwen 2 oz side effects (in more detail)

Vildagliptin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BH02

CAS registry number (Chemical Abstracts Service)

0274901-16-5

Chemical Formula

C17-H25-N3-O2

Molecular Weight

303

Therapeutic Category

Oral antidiabetic agent, dipeptidyl peptidase-4 (DPP-4) inhibitor, gliptin

Chemical Names

(S)-{[(3-Hydroxyadamantan-1-yl)amino]acetyl}pyrrolidin-2-carbonitril (IUPAC)

(2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile (WHO)

2-Pyrrolidinecarbonitrile, 1-(((3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)amino)acetyl)-, (2S)-

Foreign Names

• Vildagliptinum (Latin)
• Vildagliptin (German)
• Vildagliptine (French)
• Vildagliptina (Spanish)

Generic Names

• Vildagliptin (OS: USAN)
• DPP-728 (IS)
• DPP-728A (IS)
• LAF-237 (IS)
• NVP-DPP-728 (IS)
• NVP-LAF-237 (IS)

Brand Names

• Eucreas (Vildagliptin and Metformin)
  Novartis, Germany; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Ireland; Novartis, Netherlands; Novartis, Norway; Novartis, Sweden; Novartis, Slovenia; Novartis Europharm, Austria



• Galvumet (Vildagliptin and Metformin)
  Novartis, Switzerland



• Galvus
  Dexa Medica, Indonesia; Novartis, Bahrain; Novartis, Switzerland; Novartis, Germany; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Indonesia; Novartis, Ireland; Novartis, Italy; Novartis, Netherlands; Novartis, Norway; Novartis, Sweden; Novartis, Slovenia; Novartis Europharm, Austria; Novartis Europharm Ltd., Denmark



• Icandra (Vildagliptin and Metformin)
  Novartis, Germany



• Jalra
  Novartis, Germany; Novartis, Greece; Novartis, Slovakia



• Xiliarx
  Novartis, Slovakia

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Apo-Desmopressin

Apo-Desmopressin may be available in the countries listed below.

Ingredient matches for Apo-Desmopressin

Desmopressin

Desmopressin acetate (a derivative of Desmopressin) is reported as an ingredient of Apo-Desmopressin in the following countries:

• Canada

International Drug Name Search